Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-24

Clinical Trial Update: 1% Metformin in Moderate and Severe Periodontitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update evaluating a 1% metformin formulation in moderate to severe periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Periodontitis | Phase 2, Phase 3 | Status: COMPLETED